About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 195 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 195 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-195 of 195 trials

CompletedOpen-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.The purpose of this open-label study is to evaluate the long-term (6-month) safety and tolerability of extended-release paliperidone, an atypical antipsychotic, given in flexible…NCT00488319·Cerritos, California and 52 others CompletedA Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)This study will evaluate the efficacy of ALKS 3831 in adult subjects with acute exacerbation of schizophrenia.NCT02634346·Little Rock, Arkansas and 30 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedAssessing the Effects of Fanapt® on Social Cognition in SchizophreniaThe study looks at whether treatment with iloperidone (Fanapt) is associated with improvements in social cognition in individuals who have been recently diagnosed with…NCT01929889·Chicago, Illinois

CompletedA Study of Paliperidone Palmitate 6-Month FormulationThe purpose of this study is to demonstrate that injection cycles consisting of a single administration of paliperidone palmitate 6-month (PP6M) are not less effective than 2…NCT03345342·Rogers, Arkansas and 137 others

CompletedA Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese patients with…NCT04524403·Bentonville, Arkansas and 39 others

RecruitingA Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXTA study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophreniaNCT07061288·Los Alamitos, California and 7 others

TerminatedStudy to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaStudy to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.NCT05182476·Phoenix, Arizona and 48 others

CompletedAn Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaThe primary objective of this study was to continue to provide aripiprazole intramuscular (IM) depot treatment (400 milligrams \[mg\] or 300 mg) to participants with schizophrenia…NCT01129882·Bellevue, California and 156 others

CompletedA Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaThe primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 3831 in subjects with schizophrenia.NCT02873208·Little Rock, Arkansas and 44 others

RecruitingNBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With SchizophreniaThis study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.NCT07114874·Bryant, Arkansas and 60 others

TerminatedLong-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)This is a study of ABT-126 in the treatment of cognitive impairment associated with schizophrenia (CIAS), a long-term extension study to study M10-855 (NCT01655680).NCT01834638·Chino, California and 50 others

CompletedA Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective DisorderThis study will investigate the efficacy and safety of RO6889450 as monotherapy in participants experiencing an acute exacerbation of symptoms of schizophrenia or schizoaffective…NCT04512066·Little Rock, Arkansas and 39 others

CompletedSafety and Efficacy of Cariprazine in Patients With SchizophreniaThe objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of acute exacerbation of schizophrenia.NCT01104766·Little Rock, Arkansas and 57 others

RecruitingStudy to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderTo compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapineNCT05303064·Dothan, Alabama and 46 others

CompletedIntramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaThe purpose of the this trial is to evaluate the efficacy, safety, and tolerability of an intramuscular (IM) depot formulation of aripiprazole as maintenance treatment in patients…NCT00706654·Cerritos, California and 97 others

PreviousPage 10 of 10

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia